I dont want to sound alarmist, the 74 year-old from Clearwater, S.C., begins, but I think my eyes might last longer than I do. Well, thats my job, Nussbaum said, chuckling. After battling diabetes for nearly 40 years, Lowe has developed diabetic retinopathy, a consequence of uncontrolled diabetes that can damage small blood vessels in the eye and is the leading cause of blindness among working-age adults. A researcher across campus from the clinic is looking at a different way of potentially blocking the inflammation that can lead to that damage through a potential new drug. Dr. http://goodchristiansimmons.holyfamilyschooljasper.com/2017/01/02/almost-all-people-with-diabetes-show-signs-of-retinal-damage-after-about-20-years-of-living-with-the-condition/Shruti Sharma of the Center for Biotechnology and Genomic Medicine has a $1.5 million grant from the National Eye Institute to look at basic research into blocking inflammation among epithelial cells in light-sensing retina in the eye, Sharma is looking at a well-known agent in inflammation called interleukin-6 that can affect those cells even though they lack the receptor normally needed for such interaction, an effect called trans-signaling. While that effect had been known for a while it is not something that researchers had focused on in the past, she said. Sharma is looking at an experimental drug that in her early work seems to have blocked that type of action in those cells, using it both in the lab in human cells in the same kind of environment that is there in the eye and in a mouse model of diabetes. The hope is to prevent the barrier disruption to the cells that can cause them to become leaky and create inflammation, an early hallmark of the disease. The mouse model allows Sharma to test the compound in both late and early stages of the disease to see if it she can prevent diabetic retinopathy from happening, she said. Separately, the compound is being tested in human clinical trials in rheumatoid arthritis, which is also promising, Sharma said.
For the original version including any supplementary images or video, visit http://www.washingtontimes.com/news/2017/jan/1/new-drug-might-help-with-diabetes-related-blindnes/?utm_source=RSS_Feed&utm_medium=RSS
New blood vessels grow on the retina. To understand what happens in eye disorders, it helps to understand how the eye works. Recommended Related to Diabetes makes heart disease more likely. Diagnosing retinopathy begins with taking a thorough personal and family medical history, including symptoms, and completing a physical examination, including an extensive eye examination. All people with diabetes are at risk of developing diabetic retinopathy. If fluid leaks from the enlarged blood vessels it can build up and causes swelling oedema. Looking directly at the sun or watching an eclipse can cause damage known as Solar Retinopathy. Laser treatments may also be used. This process can pinpoint areas that may be threatening to bleed. However, patients who started the trial with 20/50 or worse vision had greater improvements in vision with Eylea. There can be partial or complete loss of vision. To help deal with mild cataracts, you may need to wear sunglasses more often and use glare-control lenses in your glasses. Read the Diabetes and Dietary Fat article > > For a person who has diabetes, the risk of developing retinopathy is directly related to the length of time that he or she has had diabetes.
The retina of a person with diabetic retinopathy and DBE, as viewed by optical coherence tomography OCR. People with diabetes can also greatly reduce the possibilities of eye complications by going to their routine examinations with an eye doctor and taking part in the national screening programme. Surgery called vitrectomy is used when there is bleeding haemorrhage into the eye. A new class of drugs has recently become available to treat macular oedema and they are often used in conjunction with the laser therapy. For cataracts that interfere greatly with vision, doctors usually remove the lens of the eye. However, close monitoring is essential. In the clinic, diagnostic devices that use A may improve the detection of subtle changes in retinal tissue and blood vessels. Both type 1 and type 2 diabetes can lead to retinal damage. Hypertensive retinopathy — Lowering blood pressure often can stop ongoing damage to the retina. http://www.allsaintsportsmouth.us/experteyedoctor/2016/12/05/the-best-questions-for-deciding-upon-details-in-eye-surgery/